GGrantIndex
← Leaderboards

Michael Kyba

Ut Southwestern Medical Center

$19,625,267
Attributed
$27,746,313
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,746,313 · 12

By mechanism

R01$14,938,434 · 5
U01$7,752,733 · 1
RC2$1,933,050 · 1
R42$1,559,533 · 1
R21$828,235 · 2
RC1$719,328 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsStem CellsNatural RegenerationMuscleProgenitorInsightGenesBaseSeriesTissuesChromatinAllelesMolecularMediatingIn VitroAffectMuscular DystrophiesTransplantationPathway InteractionsUnited StatesIn VivoD4z4Dna LesionSkeletal Muscle

Grant awards (56)

Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD$1,266,814
R42 · FY2025 · AR · contact PI
Probing the activity of DUX4 in FSHD$518,104
R01 · FY2025 · AR · contact PI
Probing the activity of DUX4 in FSHD$435,293
R01 · FY2024 · AR · contact PI
Dissecting Effects of Estrogen Deficiency on Satellite Cells and Muscle Regeneration in Females and Males$486,662
R01 · FY2023 · AG
Probing the activity of DUX4 in FSHD$448,564
R01 · FY2023 · AR · contact PI
Skeletal Muscle Stem Cells Derived from Teratomas$430,492
R01 · FY2023 · AR · contact PI
Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD$292,719
R42 · FY2023 · AR · contact PI
Advances in Skeletal Muscle Growth, Repair and Disease$15,000
R13 · FY2023 · AR · contact PI
Dissecting Effects of Estrogen Deficiency on Satellite Cells and Muscle Regeneration in Females and Males$494,862
R01 · FY2022 · AG
Probing the activity of DUX4 in FSHD$443,650
R01 · FY2022 · AR · contact PI
Skeletal Muscle Stem Cells Derived from Teratomas$426,186
R01 · FY2022 · AR · contact PI
Probing the activity of DUX4 in FSHD$521,846
R01 · FY2021 · AR · contact PI
Dissecting Effects of Estrogen Deficiency on Satellite Cells and Muscle Regeneration in Females and Males$486,409
R01 · FY2021 · AG
Skeletal Muscle Stem Cells Derived from Teratomas$417,576
R01 · FY2021 · AR · contact PI
Dissecting Effects of Estrogen Deficiency on Satellite Cells and Muscle Regeneration in Females and Males$491,012
R01 · FY2020 · AG
Probing the activity of DUX4 in FSHD$445,366
R01 · FY2020 · AR · contact PI
Skeletal Muscle Stem Cells Derived from Teratomas$430,492
R01 · FY2020 · AR · contact PI
Dissecting Effects of Estrogen Deficiency on Satellite Cells and Muscle Regeneration in Females and Males$519,020
R01 · FY2019 · AG
Skeletal Muscle Stem Cells Derived from Teratomas$427,781
R01 · FY2019 · AR · contact PI
Probing the Activity of DUX4 in FSHD$334,400
R01 · FY2019 · AR · contact PI
Probing the Activity of DUX4 in FSHD$334,400
R01 · FY2018 · AR · contact PI
Probing the Activity of DUX4 in FSHD$334,400
R01 · FY2017 · AR · contact PI
FSHD iPS Cells: Genetic Correction and Myogenesis$332,500
R01 · FY2017 · NS · contact PI
Probing the Activity of DUX4 in FSHD$334,400
R01 · FY2016 · AR · contact PI
FSHD iPS Cells: Genetic Correction and Myogenesis$332,500
R01 · FY2016 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,104,105
U01 · FY2015 · HL
Probing the Activity of DUX4 in FSHD$334,400
R01 · FY2015 · AR · contact PI
FSHD iPS Cells: Genetic Correction and Myogenesis$332,500
R01 · FY2015 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,098,208
U01 · FY2014 · HL
Molecular Pathways Regulated By DUX4, an FSHD-Associated Gene$410,663
R01 · FY2014 · AR · contact PI
FSHD iPS Cells: Genetic Correction and Myogenesis$329,176
R01 · FY2014 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,066,830
U01 · FY2013 · HL
Molecular Pathways Regulated By DUX4, an FSHD-Associated Gene$398,093
R01 · FY2013 · AR · contact PI
FSHD iPS Cells: Genetic Correction and Myogenesis$332,500
R01 · FY2013 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2012 · HL
Molecular Pathways Regulated By DUX4, an FSHD-Associated Gene$419,045
R01 · FY2012 · AR · contact PI
Development of anti-DUX4 therapeutics for FSHD$264,250
R21 · FY2012 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,120,620
U01 · FY2011 · HL
Molecular Pathways Regulated By DUX4, an FSHD-Associated Gene$419,045
R01 · FY2011 · AR · contact PI
Probing the Hematopoietic Hox Code$377,500
R01 · FY2011 · HL · contact PI
Development of anti-DUX4 therapeutics for FSHD$151,000
R21 · FY2011 · NS · contact PI
Midwestern Progenitor Cell Consortium$1,109,850
U01 · FY2010 · HL
FSHD iPS cells: Modeling disease mechanisms, genetic correction and cell therapy$974,014
RC2 · FY2010 · AR · contact PI
Molecular pathways regulated by DUX4, an FSHD-associated gene$423,277
R01 · FY2010 · AR · contact PI
Probing the Hematopoietic Hox Code$377,500
R01 · FY2010 · HL · contact PI
Lineage-specific reprogramming to blood with a transcription factor cocktail$364,979
RC1 · FY2010 · HL · contact PI
Tools to study age-related changes in muscle stem cells$224,235
R21 · FY2010 · AG · contact PI
Midwestern Progenitor Cell Consortium$1,132,500
U01 · FY2009 · HL
FSHD iPS cells: Modeling disease mechanisms, genetic correction and cell therapy$959,036
RC2 · FY2009 · AR · contact PI
Probing the Hematopoietic Hox Code$377,500
R01 · FY2009 · HL · contact PI
Lineage-specific reprogramming to blood with a transcription factor cocktail$354,349
RC1 · FY2009 · HL · contact PI
Probing the Hematopoietic Hox Code$256,096
R01 · FY2009 · HL · contact PI
Tools to study age-related changes in muscle stem cells$188,750
R21 · FY2009 · AG · contact PI
Probing the Hematopoietic Hox Code$18,724
R01 · FY2009 · HL · contact PI
Probing the Hematopoietic Hox Code$392,500
R01 · FY2008 · HL · contact PI
Probing the Hematopoietic Hox Code$314,000
R01 · FY2007 · HL · contact PI